A. Petzer

Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer

P. Kirchweger, A. Kupferthaler, H. Wundsam, 2023, Therapeutic advances in medical oncology.

Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer.

P. Kirchweger, H. Taghizadeh, G. Webersinke, 2023, ESMO open.

Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression.

Z. Bago-Horvath, E. Heitzer, G. Rinnerthaler, 2024, Molecular oncology.